Muy‐Kheng M. Tea

Pathology of Breast and Ovarian Cancers among <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers: Results from the Consortium of Investigators of Modifiers of <i>BRCA1</i> / <i>2</i> (CIMBA)

Nasim Mavaddat, Daniel Barrowdale, Irene L. Andrulis et al. · Cancer Epidemiology Biomarkers & Prevention · 2012 · 649 citations · Full text

Association of Type and Location of<i>BRCA1</i>and<i>BRCA2</i>Mutations With Risk of Breast and Ovarian Cancer

Timothy R. Rebbeck, Nandita Mitra, Fei Wan et al. · JAMA · 2015 · 484 citations · Full text

Triple-Modality Screening Trial for Familial Breast Cancer Underlines the Importance of Magnetic Resonance Imaging and Questions the Role of Mammography and Ultrasound Regardless of Patient Mutation Status, Age, and Breast Density

Christopher C. Riedl, Nikolaus Luft, Clemens Bernhart et al. · Journal of Clinical Oncology · 2015 · 300 citations · Full text

Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2

Anna Marie Mulligan, Fergus J. Couch, Daniel Barrowdale et al. · Breast Cancer Research · 2011 · 118 citations · Full text

Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients

Eva Obermayr, Fátima Sánchez‐Cabo, Muy‐Kheng M. Tea et al. · BMC Cancer · 2010 · 116 citations · Full text